Iohexol 755mg (equivalent to 350mg of organic iodine) per mL; soln; preservative-free. IV administration: in adults, for angiocardiography (ventriculography, selective coronary arteriography), ...
Amneal Pharmaceuticals announced that the U.S. FDA has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's Omnipaque, with plans to launch in the first ...
Iohexol 19mg (equivalent to 9mg of organic iodine) per mL; preservative-free. For oral use only. Give all at once or over a period of up to 45mins. 500–1000mL. See full labeling for concomitant ...
Disruptions to the global supply chain, greatly intensified since the start of the pandemic, have affected multiple industries including the health care sector, which is currently suffering from ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's ...
Iohexol is a radiographic contrast agent indicated for intrathecal, intra-arterial, intravenous, oral, rectal, intraarticular and body cavity imaging procedures. “We are very proud to introduce the ...
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced positive top line results from a Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol ...
(RTTNews) - Amneal Pharmaceuticals Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), marking the first generic version of GE ...
Amneal Pharmaceuticals (AMRX) just received U.S. FDA approval for its iohexol injection, paving the way for the first generic alternative to Omnipaque in a $652 million market. This milestone arrives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results